Key Record Dates
ClinicalTrials.gov Identifier: | NCT04588324 |
---|---|
Brief Title: | Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors |
First Submitted : | September 30, 2020 |
First Submitted that Met QC Criteria : | October 8, 2020 |
First Posted : | October 19, 2020 |
Last Update Submitted that Met QC Criteria : | October 15, 2020 |
Last Update Posted : | October 19, 2020 |